trial

Insight Enhancement Program vs. Metacognitive Training for Psychosis in Patients With Schizophrenia: A Three-Armed Comparative Randomized Controlled Trial

NCTId NCT03955549
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Completed
Enrollment 99 (actual)
Sponsored by Agiad Psychiatry Hospital
Primary completion 2021-01-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Completed
Enrollment
99 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2019-05-01
Primary completion
2021-01-30
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Insight Enhancement Program (IEP)Metacognitive Training for Psychosis (MCT)

Sponsors

Agiad Psychiatry HospitalLead Sponsor
University of Pittsburgh Medical CenterCollaborator

Investigators

2
Ahmed A. Dobie, Msc.Principal Investigator
Mai M. El-Bassosy, Msc.Principal Investigator

Sites

1 total
Ţalkhā, Egypt

Linked catalysts

1
Insight Enhancement Program vs. Metacognitive Training for Psychosis in Patients — primary completion2021-01-30

Facts & assertions

4 sourced
Enrollment
99
Phase
PHASE3
Primary Completion Date
2021-01-30
Status
COMPLETED
relationships
The graph out of here
drug
Insight Enhancement Program (IEP)
drug
Metacognitive Training for Psychosis (MCT)
drug
lead_sponsor
Agiad Psychiatry Hospital
company
collaborator
University of Pittsburgh Medical Center
company
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication
investigator
Ahmed A. Dobie, Msc.
person
Mai M. El-Bassosy, Msc.
person